A

Acrivon Therapeutics Inc
NASDAQ:ACRV

Watchlist Manager
Acrivon Therapeutics Inc
NASDAQ:ACRV
Watchlist
Price: 2.39 USD 3.02% Market Closed
Market Cap: 75.4m USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of ACRV.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ACRV Intrinsic Value
Not Available
Base Case Scenario
Compare ACRV to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ACRV?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Acrivon Therapeutics Inc

Current Assets 130.4m
Cash & Short-Term Investments 129.3m
Other Current Assets 1.1m
Non-Current Assets 14.9m
Long-Term Investments 5.1m
PP&E 8m
Other Non-Current Assets 1.8m
Current Liabilities 14.9m
Accounts Payable 996k
Accrued Liabilities 13.9m
Non-Current Liabilities 1.8m
Other Non-Current Liabilities 1.8m
Efficiency

Free Cash Flow Analysis
Acrivon Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Acrivon Therapeutics Inc

Revenue
0 USD
Operating Expenses
-89m USD
Operating Income
-89m USD
Other Expenses
7.2m USD
Net Income
-81.8m USD
Fundamental Scores

ACRV Profitability Score
Profitability Due Diligence

Acrivon Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Low 3Y Average Operating Margin
Negative ROE
hidden
Profitability
Score

Acrivon Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

ACRV Solvency Score
Solvency Due Diligence

Acrivon Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
hidden
Solvency
Score

Acrivon Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ACRV Price Targets Summary
Acrivon Therapeutics Inc

Wall Street analysts forecast ACRV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ACRV is 11.39 USD with a low forecast of 6.06 USD and a high forecast of 19.95 USD.

Lowest
Price Target
6.06 USD
154% Upside
Average
Price Target
11.39 USD
377% Upside
Highest
Price Target
19.95 USD
735% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Acrivon Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ACRV is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

ACRV Insider Trading
Buy and sell transactions by insiders